A novel role of master regulator transcription factor in anti-tumor immunity and cancer immunotherapy is a research paper published in Theranostics (2023). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: P30 CA014089
NCI NIH HHS
Grant: R37 CA237022
National Institutes of Health
Grant: 5R37CA237022-04
Master regulator transcription factors promote esophageal neoplastic evolution
National Institutes of Health
Grant: 3P30CA014089-17S1
USC COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
FWCI
0.38
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals